Alimera Sciences

ALIM58

$5.540.00%$0.00

ALIM58

$5.54

0.00%$0.00

Performance History

Key Stats
Open	$5.54
Prev. Close	$5.54
EPS	1.05
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-

	LOW	HIGH
Day Range	5.54	5.54
52 Week Range	2.60	5.65

Ratios







EPS	1.05

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Alimera Sciences (ALIM)

Alimera Sciences Inc (ALIM) is a pharmaceutical company specializing in the research, development, and commercialization of ophthalmic products. The company's primary focus is the treatment of diabetic macular edema (DME), a leading cause of vision loss in diabetic patients. Through its innovative drug delivery systems, Alimera Sciences aims to provide long-lasting and effective solutions for this debilitating condition.

With a rich history of pioneering advancements in ophthalmology, Alimera Sciences has established itself as a leader in the field. The company's flagship product, Iluvien, is an intravitreal implant designed to release a sustained dose of fluocinolone acetonide, a steroid medication that reduces inflammation and edema in the eye. Iluvien has been approved for use in multiple countries and has shown promising results in clinical trials.

Websitecall_made

Sector: Healthcare
Industry: Drug Manufacturers—Specialty & Generic
CEO: Mr. Richard S. Eiswirth Jr.
Headquarters: Alpharetta
Employees: 150
Exchange: NASDAQ

Keep an eye on Alimera Sciences

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Alimera Sciences 's (ALIM) price per share?

The current price per share for Alimera Sciences (ALIM) is $5.54. The stock has seen a price change of $0 recently, indicating a 0% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Alimera Sciences (ALIM)?

For Alimera Sciences (ALIM), the 52-week high is $5.65, which is 1.99% from the current price. The 52-week low is $2.61, the current price is 112.59% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Alimera Sciences (ALIM) a growth stock?

Alimera Sciences (ALIM) has shown an average price growth of 0.41% over the past three years. It has received a score of 34 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Alimera Sciences as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Alimera Sciences (ALIM) stock price performance year to date (YTD)?

As of the latest data, Alimera Sciences (ALIM) has a year-to-date price change of 35.78%. Over the past month, the stock has experienced a price change of -0.89%. Over the last three months, the change has been 75.87%. Over the past six months, the figure is 37.81%. Looking at a longer horizon, the five-year price change stands at -38.58%.

help

Is Alimera Sciences (ALIM) a profitable company?

Alimera Sciences (ALIM) has a net income of -$20.13M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 75.75% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 7.86% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $80.75M, with a revenue growth rate of 49.19%, providing insight into the company's sales performance and growth. The gross profit is $61.17M. Operating income is noted at -$1.47M. Furthermore, the EBITDA is $12.58M.

help

What is the market capitalization of Alimera Sciences (ALIM)?

Alimera Sciences (ALIM) has a market capitalization of $301.29M. The average daily trading volume is 2.6M, indicating the stock's liquidity and investor engagement.